BeyondSpring Inc.

12/01/2021 | Press release | Distributed by Public on 12/01/2021 15:53

BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)